{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: STZ treatment showed decrease expression of post synaptic markers CaMKIIa and PSD - 95 , while , expression of pre synaptic markers ( synaptophysin and SNAP - 25 ) remains unaltered indicating selective post synaptic neurotoxicity .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| selective post synaptic neurotoxicity |\n\nExplanation:\n\nIn the given paragraph, there is only one disease entity mentioned, which is \"selective post synaptic neurotoxicity.\" Neurotoxicity refers to damage to the nervous system or its cells due to exposure to certain substances or toxins. Therefore, \"selective post synaptic neurotoxicity\" is a disease entity where there is selective damage to the post-synaptic region of the neuron."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| selective post synaptic neurotoxicity |\n\nExplanation:\n\nIn the given paragraph, there is only one disease entity mentioned, which is \"selective post synaptic neurotoxicity.\" Although \"CaMKIIa,\" \"PSD - 95,\" \"synaptophysin,\" and \"SNAP - 25\" are names of proteins or markers, they do not clearly refer to diseases. Therefore, they are not included in the table."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: STZ treatment showed decrease expression of post synaptic markers CaMKIIa and PSD - 95 , while , expression of pre synaptic markers ( synaptophysin and SNAP - 25 ) remains unaltered indicating selective post synaptic neurotoxicity .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| STZ |\n| CaMKIIa |\n| PSD - 95 |\n| synaptophysin |\n| SNAP - 25 |\n\nExplanation:\n\n* STZ: Streptozotocin, a chemical commonly used in scientific research to induce diabetes in laboratory animals.\n* CaMKIIa: Calcium/calmodulin-dependent protein kinase II alpha, an important protein kinase in synaptic plasticity.\n* PSD - 95: Postsynaptic density protein 95, a scaffolding protein found in the postsynaptic density of excitatory synapses.\n* synaptophysin: A major synaptic vesicle protein that is widely used as a marker for presynaptic terminals.\n* SNAP - 25: Synaptosomal-associated protein 25, a component of the SNARE complex involved in neurotransmitter release."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| STZ |\n\nExplanation:\n\n* STZ: Streptozotocin, a chemical commonly used in scientific research to induce diabetes in laboratory animals.\n\nThe other entities mentioned in the paragraph, such as CaMKIIa, PSD - 95, synaptophysin, and SNAP - 25, are proteins, not chemicals. Therefore, they do not meet the criteria for being considered \"Chemical\" entities."}
  ]
}